Company Filing History:
Years Active: 2008
Title: Innovations by Chung Nan Weng in Mycoplasma Vaccine Development
Introduction
Chung Nan Weng is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for livestock. His work focuses on addressing critical health issues in pigs, which are vital to the agricultural industry.
Latest Patents
Chung Nan Weng holds a patent for a mycoplasma vaccine, which includes a method of making and applying the vaccine. The invention provides a mycoplasma vaccine that comprises inactivated ATIT-7 or a mixture of inactivated ATIT-7 and other components. This vaccine effectively prevents the infection of swine enzootic pneumonia in pigs, showcasing its importance in maintaining animal health and productivity.
Career Highlights
Chung Nan Weng is associated with the Animal Technology Institute Taiwan, where he has been instrumental in advancing research and development in animal health. His expertise in vaccine development has positioned him as a key figure in the field, contributing to innovative solutions for livestock diseases.
Collaborations
Chung Nan Weng collaborates with Jiunn Horng Lin, working together to enhance the effectiveness of veterinary vaccines and improve animal health outcomes.
Conclusion
Chung Nan Weng's contributions to the development of mycoplasma vaccines represent a significant advancement in veterinary medicine. His innovative work continues to impact the agricultural sector positively.